38
Participants
Start Date
September 14, 2022
Primary Completion Date
May 23, 2024
Study Completion Date
May 23, 2024
Low-dose acetylsalicylic acid
In case of being positive for SARS-CoV-2 PCR or antigen test, she will be randomised 1:1 to receive daily LDASA (125 mg) or placebo, up to 36 weeks of pregnancy.
Placebo
Placebo
Universidade Eduardo Mondlane, Maputo
Hospital Universitario de Torrejón, Torrejón de Ardoz
Hospital del Mar, Barcelona
Hospital Sant Joan de Déu, Barcelona
Hospital Universitario de Torrejón
UNKNOWN
Hospital Universitario Infanta Leonor
OTHER
Hospital Sant Joan de Deu
OTHER
Hospital del Mar
OTHER
Eduardo Mondlane University
OTHER
Hospital Central de Maputo
UNKNOWN
Hospital Geral de Mavalane
UNKNOWN
Hospital Geral José Macamo
UNKNOWN
Barcelona Institute for Global Health
OTHER